Natco Pharma Limited Sofosbuvir Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Sofosbuvir Export Records India — #4 Exporter, 16 Shipments, $800.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sofosbuvir

India Pharmaceutical Trade Intelligence

$40.9M150 Suppliers113 CountriesHS 30049099

ExportsIndia → VIETNAM12.4%India → ETHIOPIA9.2%

ImportsUNITED STATES → India$206.1K GERMANY → India$43.1K

#1 Supplier: MYLAN LABORATORIES

Natco Pharma Limited — Sofosbuvir Exporter #4 | $800.0K Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Sofosbuvir Exporter Profile

Indian Pharmaceutical Exporter · #4 for Sofosbuvir · $800.0K export value · DGFT Verified

Natco Pharma Limited is the #4 Indian exporter of Sofosbuvir with $800.0K in export value and 16 verified shipments. Natco Pharma Limited holds a 2.0% market share in Sofosbuvir exports across 7 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Sofosbuvir Export Profile: Buyers & Destinations

Natco Pharma Limited Sofosbuvir export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Sofosbuvir?

Country	Value	Shipments	Share
FRANCE	$115.6K	3	29.6%
PHILIPPINES	$88.0K	4	22.6%
ARMENIA	$81.8K	3	21.0%
VIETNAM	$50.0K	1	12.8%
BURUNDI	$29.4K	2

Who Are the Top Buyers of Sofosbuvir from Natco Pharma Limited?

Buyer	Country	Value	Orders
MSF LOG BDX SITE MERIGNAC	FRANCE	$65.6K	2
INTEGRATED MARKET SERVICES	PHILIPPINES	$64.4K	3
VIOLETA MEDICAL CENTER GUSAN SHERAM	ARMENIA	$50.0K	1
MSF LOG-BDX SITE MERIGNAC	FRANCE	$50.0K	1
DELTA IMPORT-EXPORT MEDICAL	VIETNAM	$50.0K	1
UNIDIS HEALTHCARE PRIVATE LIMITED	BURUNDI	$29.4K	2
INTEGRATED MARKET SERVICES (PHILIPP	PHILIPPINES	$23.6K	1
VIOLETA PHARMA	ARMENIA	$18.3K	1
TOO ROGERS PHARMA	KAZAKISTAN	$17.9K	1
VIOLETA MEDICAL CENTER	ARMENIA	$13.5K	1

Natco Pharma Limited supplies Sofosbuvir to 11 buyers globally. The largest buyer is MSF LOG BDX SITE MERIGNAC (FRANCE), followed by INTEGRATED MARKET SERVICES (PHILIPPINES) and VIOLETA MEDICAL CENTER GUSAN SHERAM (ARMENIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sofosbuvir Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
VELPATASVIR 100MG + SOFOSBUVIR 400MG TABLETS 28'S VELPANATOTHER REFERENCE CINO:123060	$50.0K	1
SOFOSBUVIRSOF400MG/VELPATASVIRVEL100MGTABLETS28'SVELPANATAPPENDIX4RRODTEPENTRY NO:10153OTHER REFS CI NO:62300	$50.0K	1
SOFOSBUVIR(SOF)400MG/VELPATASVIR(VEL) 100MG TABLETS 28'S (VELPANAT)(3612X28'S)(APPENDIX 4R, RODTEP ENTRY NO:10153)	$50.0K	1
VELSOF 28'S TABLETS (VELPATASVIR 100MG +SOFOSBUVIR 400MG)(3270X28'S)(APPENDIX 4R,RODTEP ENTRY NO:10153)	$50.0K	1
VELPANAT (400MG/100MG SOFOSBUVIR & VELPAASVIR) (500 X 28'S)NOS	$34.7K	1
VELPANAT TABLETS (400MG/100MG SOFOSBUVIR	$25.6K	1
VELPANAT TAB (400MG/100MG SOFOSBUVIR & V	$23.6K	1
VELPANAT TABLETS (SOFOSBUVIR AND VELPATASVIR 400MG/100MG TABLETS)(500X28'S)(APPENDIX 4R, RODTEP ENTRY NO:10153)	$18.3K	1
SOFOSBUVIR & VELPATSVIR 400MG/100MG TABLETS 28'S (APPENDIX 4R, RODTEP ENTRY NO:10153)(OTHER REFERENCE CI NO:123299)	$17.9K	1
SOFOSBUVIR SOF 400MG/VELPATASVIRVEL100MG TABLETS 28S VELPANAT257X28SOTHER REF CI NO: 623012APPENDIX 4RRODTEP	$15.6K	1

Natco Pharma Limited exports 16 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VELPATASVIR 100MG + SOFOSBUVIR 400MG TABLETS 28'S VELPANATOT with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Natco Pharma Limited Compare to Nearest Sofosbuvir Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED	$9.9M	199	44	$50.0K
2	HETERO LABS LIMITED	$5.3M	105	18	$50.0K
4	NATCO PHARMA LIMITED ★	$800.0K	16	7	$50.0K
5	HEET HEALTHCARE PRIVATE LIMITED	$370.8K	116	12	$3.2K
3	EURO LIFECARE PRIVATE LIMITED	$350.0K	7	2	$50.0K

Natco Pharma Limited ranks #4 among 150 Indian Sofosbuvir exporters. Average shipment value of $50.0K compared to the market average of $120.8K. The closest competitors by value are MYLAN LABORATORIES LIMITED and HETERO LABS LIMITED.

Which Indian Ports Ship Sofosbuvir Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	357	26.6%
SAHAR AIR	269	20.1%
DELHI AIR CARGO ACC (INDEL4)	158	11.8%
Bombay Air	126	9.4%
DELHI AIR	79	5.9%
AHEMDABAD AIR	68	5.1%
AHEMDABAD AIR ACC (INAMD4)	50	3.7%
HYDERABAD ACC (INHYD4)	39	2.9%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Sofosbuvir Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sofosbuvir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 16 individual customs records matching Natco Pharma Limited exporting Sofosbuvir, covering 16 formulations to 7 countries via 11 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 377+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sofosbuvir

Sofosbuvir

Natco Pharma Limited — Sofosbuvir Exporter Profile

Natco Pharma Limited — Sofosbuvir Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Sofosbuvir?

Who Are the Top Buyers of Sofosbuvir from Natco Pharma Limited?

What Is India's Total Sofosbuvir Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Sofosbuvir Exports?

How Does Natco Pharma Limited Compare to Other Indian Sofosbuvir Exporters?

What Sofosbuvir Formulations Does Natco Pharma Limited Export?

How Does Natco Pharma Limited Compare to Nearest Sofosbuvir Exporters?

Which Indian Ports Ship Sofosbuvir Exports?

What Other Antiviral & HIV Medications Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Sofosbuvir Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sofosbuvir Export Data from Natco Pharma Limited

Sofosbuvir Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source